The authors' work is supported by the European Network for Translational Research in Atrial Fibrillation (EUTRAF, No. 261057), the German Federal Ministry of Education and Research (AF Competence ...

PARIS — Early radiofrequency ablation was superior to antiarrhythmic drugs to delay the progression to persistent atrial fibrillation among patients with drug-refractory paroxysmal AF, according to ...

Please provide your email address to receive an email when new articles are posted on . “Currently, contemporary guidelines recommend a trial of antiarrhythmic drugs prior to considering catheter ...

There are two general approaches to treating atrial fibrillation: Attempt to get rid of the atrial fibrillation altogether and restore and maintain normal heart rhythm. Allow the atrial fibrillation ...

If you suffer from atrial fibrillation (AF)—a condition where disorganized electrical signals cause the heart's upper chambers to contract quickly and irregularly—your doctor may prescribe an ...

Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular ...

The human voltage-gated sodium channel, hNaV1.5, is responsible for the rapid upstroke of the cardiac action potential and is target for antiarrhythmic therapy. Despite the clinical relevance of hNaV1 ...

Atrial fibrillation, also known as AFib, is the most common type of irregular heartbeat, and it is associated with increased mortality. While researchers have identified a causal link between obesity ...

Upfront catheter ablation is a better first-line strategy for patients who develop ventricular tachycardia (VT) after a myocardial infarction (MI) than waiting until antiarrhythmic drugs fail, a ...

This is a preview. Log in through your library . Abstract Purpose Long-term usage of the antiarrhythmic drug digoxin has been connected to lowered risk of prostate cancer. A recent study has suggested ...

Active ingredient: Dronedarone 400 mg; tabs. Indication: To reduce risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL) ...